Dozens of diseases cause inflammation, ranging from autoimmune conditions like rheumatoid arthritis and lupus to metabolic disorders like type 2 diabetes, cardiovascular disease, and neurodegenerative conditions like Alzheimer’s. Some trigger intense, short-lived inflammatory episodes. Others produce a slow-burning, chronic inflammation that damages tissues over months or years, often without obvious symptoms until significant harm is done.
Understanding which diseases drive inflammation, and how they do it, helps explain why conditions that seem completely unrelated (joint pain, plaque in your arteries, brain fog) actually share common biological roots.
Two Types of Immune Malfunction
Diseases that cause inflammation generally fall into two camps based on which branch of your immune system goes wrong. Autoimmune diseases occur when your adaptive immune system, the part that learns to recognize specific threats over time, mistakenly targets your own tissues. Rheumatoid arthritis, lupus, type 1 diabetes, and multiple sclerosis all work this way. Your body builds a targeted attack against its own cells as if they were foreign invaders.
Autoinflammatory diseases are different. These involve your innate immune system, the broad, first-line defenses you’re born with. Instead of a targeted attack, the body triggers waves of inflammation in healthy tissue without a specific immune “memory” driving it. Conditions like familial Mediterranean fever and gout fall into this category. The distinction matters because the two types respond to different treatments, even though the symptoms (swelling, pain, fatigue) can look similar.
Autoimmune Diseases
Rheumatoid Arthritis
In rheumatoid arthritis, the immune system attacks the lining of the joints, producing inflammatory signaling molecules that drive swelling, pain, and eventual joint destruction. These same molecules don’t stay contained to the joints. They can cross into the brain, disrupt the barrier that normally protects it, and activate the brain’s own immune cells. This is why people with rheumatoid arthritis frequently experience fatigue, depression, and difficulty concentrating, not just joint symptoms. The inflammation also shifts how the body processes serotonin’s building blocks, diverting them toward compounds linked to depressive symptoms and cognitive problems.
Psoriasis
Psoriasis is now recognized as far more than a skin condition. The chronic inflammation it generates circulates throughout the body and raises the risk of heart attack, high blood pressure, abnormal cholesterol, diabetes, blood clots, and pulmonary embolism. The severity of the skin disease correlates directly with the level of systemic inflammation, measured by markers like C-reactive protein and a signaling molecule called IL-6. This is why treatments that reduce psoriasis inflammation often improve cardiovascular risk markers too.
Inflammatory Bowel Disease
Crohn’s disease and ulcerative colitis are the two main forms of inflammatory bowel disease. Both involve an abnormal immune response to gut bacteria in people with a genetic predisposition, but they affect different parts of the digestive tract. The inflammation produces measurable changes: reduced blood protein levels, elevated inflammatory markers in the blood, and high levels of a protein called fecal calprotectin in stool samples. Calprotectin is particularly useful because it correlates well with visible inflammation during endoscopy and helps distinguish IBD from irritable bowel syndrome, which doesn’t involve structural inflammation.
One complicating factor: standard blood markers like C-reactive protein and sedimentation rate can be normal in up to 40% of IBD patients who have clear inflammation visible on endoscopy. This means normal blood work doesn’t rule out active disease.
Cardiovascular Disease
Atherosclerosis, the buildup of plaque in arteries, was once thought to be a simple plumbing problem where fat accumulated on artery walls. It’s actually an inflammatory disease at every stage. Inflammation initiates plaque formation, drives its growth, and ultimately causes the rupture that triggers heart attacks and strokes.
The process starts when immune cells in artery walls gobble up cholesterol particles and become foam cells, forming the core of a plaque. Inflammatory signals then recruit smooth muscle cells that break down the structural proteins holding the artery wall together, allowing the plaque to expand. Over time, those same inflammatory signals weaken the fibrous cap covering the plaque by breaking down collagen and preventing new collagen from being made. When the cap becomes thin enough to rupture, the inflammatory environment inside the plaque activates a powerful clotting factor that triggers the blood clot responsible for most heart attacks.
Chronically elevated C-reactive protein, even at low levels, predicts cardiovascular events independently of traditional risk factors like cholesterol and blood pressure. This is why inflammation has become a target for cardiovascular prevention, not just cholesterol reduction.
Type 2 Diabetes and Obesity
Excess body fat doesn’t just store energy. It generates a chronic, low-grade inflammation sometimes called “meta-inflammation.” As fat cells enlarge, immune cells called macrophages infiltrate fat tissue and cluster around dying fat cells in ring-shaped formations. These macrophages shift into a pro-inflammatory state and release signals that interfere with insulin’s ability to work properly.
One key player is a macrophage-derived molecule called galectin-3, which reaches biologically significant levels in the blood of obese individuals and directly impairs insulin signaling while also recruiting more inflammatory immune cells to fat tissue. Other inflammatory molecules produced in this environment further worsen insulin resistance, creating a self-reinforcing cycle: more inflammation leads to worse blood sugar control, which leads to more fat accumulation and more inflammation. This is why weight loss, even modest amounts, can meaningfully improve both inflammation and blood sugar.
Neurodegenerative Diseases
Inflammation in the brain follows a pattern seen elsewhere in the body but with higher stakes, because brain cells regenerate poorly. Microglia, the brain’s resident immune cells, normally patrol for threats and clean up cellular debris. In neurodegenerative diseases like Alzheimer’s, Parkinson’s, and ALS, these cells become chronically activated and stuck in a pro-inflammatory state. Instead of resolving damage, they produce a sustained flood of inflammatory molecules, reactive oxygen species, and other signals that kill neurons and block repair.
Healthy microglia are flexible. They can shift between a protective, anti-inflammatory mode and an aggressive, pro-inflammatory mode depending on what’s happening around them. In neurodegeneration, this flexibility breaks down. The cells lock into their destructive phenotype, and the resulting chronic neuroinflammation becomes a common thread across otherwise distinct diseases. This is why researchers increasingly view Alzheimer’s, Parkinson’s, and ALS as having a shared inflammatory component, even though each disease has its own primary triggers and affected brain regions.
Acute Infections and Sepsis
Infections cause inflammation by design. Your immune system detects molecular signatures on bacteria, viruses, or fungi and launches an inflammatory response to contain and destroy them. Normally, this resolves once the infection clears. In sepsis, the response spirals out of control into what’s called a cytokine storm: a massive, simultaneous release of inflammatory signals that damages the body’s own organs.
Two converging problems drive this escalation. First, the immune system’s pathogen sensors become hypersensitive, amplifying the alarm signal far beyond what’s needed. Second, inflammatory forms of cell death release the contents of dying cells into surrounding tissue, which the immune system interprets as further evidence of damage, triggering even more inflammation. The result is a feedback loop where the immune response itself becomes the primary threat, causing widespread tissue injury and organ failure. COVID-19 brought this mechanism into public awareness, as the virus could trigger synergistic inflammatory cell death pathways that amplified the cytokine storm.
How Doctors Measure Inflammation
If you’re experiencing symptoms that suggest chronic inflammation, your doctor will likely start with blood tests. C-reactive protein (CRP) is the most widely used marker. It rises in response to inflammation almost anywhere in the body, making it useful as a screening tool but not very specific about the source. Erythrocyte sedimentation rate (ESR) is another common test that measures how quickly red blood cells settle in a tube, which happens faster when inflammatory proteins are present in the blood.
Neither test can tell you which disease is causing the inflammation. They can, however, help distinguish inflammatory conditions from non-inflammatory ones and track whether treatment is working. For gut-specific inflammation, fecal calprotectin offers more targeted information, with levels above 100 micrograms per gram generally suggesting intestinal inflammation rather than a functional condition like IBS. Blood and urine tests can also rule out bacterial or viral infections as the source, while a comprehensive metabolic panel checks for organ damage that might result from prolonged inflammation.
The tricky part is that inflammation doesn’t always show up on standard tests. Some conditions, particularly ulcerative colitis, can have active inflammation with completely normal CRP and ESR levels. This is why doctors often combine lab work with imaging or direct visualization through procedures like endoscopy when inflammation is suspected but markers come back normal.